Evaluation of a Human T Cell-Targeted Multi-Epitope Vaccine for Q Fever in Animal Models of Coxiella burnetii Immunity.
Saved in:
| Title: | Evaluation of a Human T Cell-Targeted Multi-Epitope Vaccine for Q Fever in Animal Models of Coxiella burnetii Immunity. |
|---|---|
| Authors: | Sluder AE; Vaccine and Immunotherapy Center, Massachusetts General Hospital, Boston, MA, United States., Raju Paul S; Vaccine and Immunotherapy Center, Massachusetts General Hospital, Boston, MA, United States., Moise L; EpiVax, Inc., Providence, RI, United States., Dold C; Oxford Vaccine Group, Department of Paediatrics, The National Institute for Health Research (NIHR) Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom., Richard G; EpiVax, Inc., Providence, RI, United States., Silva-Reyes L; Oxford Vaccine Group, Department of Paediatrics, The National Institute for Health Research (NIHR) Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom., Baeten LA; Department of Biomedical Sciences, Colorado State University, Fort Collins, CO, United States., Scholzen A; Innatoss Laboratories B.V., Oss, Netherlands., Reeves PM; Vaccine and Immunotherapy Center, Massachusetts General Hospital, Boston, MA, United States., Pollard AJ; Oxford Vaccine Group, Department of Paediatrics, The National Institute for Health Research (NIHR) Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom., Garritsen A; Innatoss Laboratories B.V., Oss, Netherlands., Bowen RA; Department of Biomedical Sciences, Colorado State University, Fort Collins, CO, United States., De Groot AS; EpiVax, Inc., Providence, RI, United States., Rollier C; Oxford Vaccine Group, Department of Paediatrics, The National Institute for Health Research (NIHR) Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom., Poznansky MC; Vaccine and Immunotherapy Center, Massachusetts General Hospital, Boston, MA, United States. |
| Source: | Frontiers in immunology [Front Immunol] 2022 May 16; Vol. 13, pp. 901372. Date of Electronic Publication: 2022 May 16 (Print Publication: 2022). |
| Publication Type: | Journal Article; Research Support, U.S. Gov't, Non-P.H.S. |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 35651616 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Evaluation of a Human T Cell-Targeted Multi-Epitope Vaccine for Q Fever in Animal Models of Coxiella burnetii Immunity. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Sluder+AE%22">Sluder AE</searchLink>; Vaccine and Immunotherapy Center, Massachusetts General Hospital, Boston, MA, United States.<br /><searchLink fieldCode="AU" term="%22Raju+Paul+S%22">Raju Paul S</searchLink>; Vaccine and Immunotherapy Center, Massachusetts General Hospital, Boston, MA, United States.<br /><searchLink fieldCode="AU" term="%22Moise+L%22">Moise L</searchLink>; EpiVax, Inc., Providence, RI, United States.<br /><searchLink fieldCode="AU" term="%22Dold+C%22">Dold C</searchLink>; Oxford Vaccine Group, Department of Paediatrics, The National Institute for Health Research (NIHR) Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Richard+G%22">Richard G</searchLink>; EpiVax, Inc., Providence, RI, United States.<br /><searchLink fieldCode="AU" term="%22Silva-Reyes+L%22">Silva-Reyes L</searchLink>; Oxford Vaccine Group, Department of Paediatrics, The National Institute for Health Research (NIHR) Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Baeten+LA%22">Baeten LA</searchLink>; Department of Biomedical Sciences, Colorado State University, Fort Collins, CO, United States.<br /><searchLink fieldCode="AU" term="%22Scholzen+A%22">Scholzen A</searchLink>; Innatoss Laboratories B.V., Oss, Netherlands.<br /><searchLink fieldCode="AU" term="%22Reeves+PM%22">Reeves PM</searchLink>; Vaccine and Immunotherapy Center, Massachusetts General Hospital, Boston, MA, United States.<br /><searchLink fieldCode="AU" term="%22Pollard+AJ%22">Pollard AJ</searchLink>; Oxford Vaccine Group, Department of Paediatrics, The National Institute for Health Research (NIHR) Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Garritsen+A%22">Garritsen A</searchLink>; Innatoss Laboratories B.V., Oss, Netherlands.<br /><searchLink fieldCode="AU" term="%22Bowen+RA%22">Bowen RA</searchLink>; Department of Biomedical Sciences, Colorado State University, Fort Collins, CO, United States.<br /><searchLink fieldCode="AU" term="%22De+Groot+AS%22">De Groot AS</searchLink>; EpiVax, Inc., Providence, RI, United States.<br /><searchLink fieldCode="AU" term="%22Rollier+C%22">Rollier C</searchLink>; Oxford Vaccine Group, Department of Paediatrics, The National Institute for Health Research (NIHR) Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Poznansky+MC%22">Poznansky MC</searchLink>; Vaccine and Immunotherapy Center, Massachusetts General Hospital, Boston, MA, United States. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2022 May 16; Vol. 13, pp. 901372. <i>Date of Electronic Publication: </i>2022 May 16 (<i>Print Publication: </i>2022). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, U.S. Gov't, Non-P.H.S. – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35651616 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fimmu.2022.901372 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 901372 Titles: – TitleFull: Evaluation of a Human T Cell-Targeted Multi-Epitope Vaccine for Q Fever in Animal Models of Coxiella burnetii Immunity. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Sluder AE – PersonEntity: Name: NameFull: Raju Paul S – PersonEntity: Name: NameFull: Moise L – PersonEntity: Name: NameFull: Dold C – PersonEntity: Name: NameFull: Richard G – PersonEntity: Name: NameFull: Silva-Reyes L – PersonEntity: Name: NameFull: Baeten LA – PersonEntity: Name: NameFull: Scholzen A – PersonEntity: Name: NameFull: Reeves PM – PersonEntity: Name: NameFull: Pollard AJ – PersonEntity: Name: NameFull: Garritsen A – PersonEntity: Name: NameFull: Bowen RA – PersonEntity: Name: NameFull: De Groot AS – PersonEntity: Name: NameFull: Rollier C – PersonEntity: Name: NameFull: Poznansky MC IsPartOfRelationships: – BibEntity: Dates: – D: 16 M: 05 Text: 2022 May 16 Type: published Y: 2022 Identifiers: – Type: issn-electronic Value: 1664-3224 Numbering: – Type: volume Value: 13 Titles: – TitleFull: Frontiers in immunology Type: main |
| ResultId | 1 |